Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-06-02
1998-11-03
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514456, 514457, 514459, 514460, 514517, A61K 31165
Patent
active
058308865
ABSTRACT:
Steroid sulphatase inhibitors and pharmaceutical compositions containing them for use in the treatment of oestrone dependent tumors, especially breast cancer. The steroid sulphatase are sulphamate esters of formula (I): ##STR1## where R.sub.1 and R.sub.2 are each H, alkyl, alkenyl, cycloalkyl or aryl, or together represent an alkylene group optionally containing a heteroatom e.g. --O-- or --NH--; and --O- polycycle represents the residue of a polycyclic alcohol such as a sterol, preferably a 3-sterol.
REFERENCES:
Townsley et al, Research Steriods, 5, 73-78, 1973.
Schwarz et al, Pharmagie 30, 17-21, 1975.
Zeitschrift fur Chemie, Schwarz et al 14(1) 1974 pp. 15-16.
Lloyd Potter Barry Victor
Reed Michael John
Cook Rebecca
Imperial College of Science Technology and Medicine
LandOfFree
Steroid sulphatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroid sulphatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid sulphatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689346